Catecholamine Dysregulation in Former American Football Players: Findings From the DIAGNOSE CTE Research Project

Authors

Suzan van Amerongen, Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, the Netherlands.
Elaine R. Peskind, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle.
Yorghos Tripodis, Department of Biostatistics, Boston University School of Public Health, MA.
Charles H. Adler, Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale.
Laura J. Balcer, Departments of Neurology, Population Health and Ophthalmology, NYU Grossman School of Medicine, New York, NY.
Charles Bernick, Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV.
Michael L. Alosco, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, MA.
Douglas Katz, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, MA.
Sarah J. Banks, Departments of Neuroscience and Psychiatry, University of California, San Diego.
William B. Barr, Departments of Neurology, Population Health and Ophthalmology, NYU Grossman School of Medicine, New York, NY.
Robert C. Cantu, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, MA.
David W. Dodick, Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale.
Yonas E. Geda, Department of Neurology and the Franke Global Neuroscience Education Center, Barrow Neurological Institute, Phoenix, AZ.
Jesse Mez, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, MA.
Jennifer V. Wethe, Department of Psychiatry and Psychology, Mayo Clinic School of Medicine, Mayo Clinic Arizona, Scottsdale.
Jason L. Weller, Department of Neurology, University of Florida Health, Jacksonville.
Daniel H. Daneshvar, Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA.
Joseph Palmisano, Biostatistics and Epidemiology Data Analytics Center (BEDAC) Boston University School of Public Health, MA.
Tess Fagle, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, MA.
Minna Holleck, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, MA.
Bailey Kossow, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, MA.
Surya Pulukuri, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, MA.
Fatima Tuz-Zahra, Department of Biostatistics, Boston University School of Public Health, MA.
Elizabeth Colasurdo, Veterans Affairs Northwest Mental Illness Research, Education, and Clinical Center, Seattle, WA.
Carl Sikkema, Veterans Affairs Northwest Mental Illness Research, Education, and Clinical Center, Seattle, WA.
Jeffrey Iliff, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle.
Ge Li, Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle.
Martha E. Shenton, Psychiatry Neuroimaging Laboratory, Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Eric M. Reiman, Banner Alzheimer's Institute, University of Arizona, Arizona State University, Translational Genomics Research Institute, and Arizona Alzheimer's Consortium, Phoenix.
Jeffrey L. Cummings, Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas; and.
Robert A. Stern, Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, MA.

Document Type

Article

Abstract

BACKGROUND AND OBJECTIVES: Disturbances in brain catecholamine activity may be associated with symptoms after exposure to repetitive head impacts (RHIs) or related chronic traumatic encephalopathy (CTE). In this article, we studied CSF catecholamines in former professional and college American football players and examined the relationship with football proxies of RHI exposure, CTE probability, cognitive performance, neuropsychiatric symptoms, and parkinsonism. METHODS: In this observational cross-sectional study, we examined male former American football players, professional ("PRO") or college ("COL") level, and asymptomatic unexposed male ("UE") individuals from the DIAGNOSE CTE Research Project. Catecholamines-norepinephrine (NE) and its metabolite, 3,4-dihydroxyphenylglycol (DHPG), and dopamine (DA) and its precursor, 3,4-dihydroxyphenylalanine (l-DOPA), and metabolite, 3,4-dihydroxyphenylacetic acid (DOPAC)-were measured in CSF with high-performance liquid chromatography and compared across groups with analysis of covariance. Multivariable linear regression models tested the relationship between CSF catecholamines and proxies of RHI exposure (e.g., total years of playing American football), factor scores for cognition, and neurobehavioral dysregulation (explosivity, emotional dyscontrol, impulsivity, affective lability), as well as depressive/anxiety symptoms, measured with the Beck Depression/Anxiety Inventories. CTE probability and parkinsonism were assessed using the National Institute of Neurological Disorders and Stroke consensus diagnostic criteria for traumatic encephalopathy syndrome (TES), and biomarkers were compared among different diagnostic groups. RESULTS: The cohort consisted of 120 former American football players (85 PRO players, 35 COL players) and 35 UE participants (age 45-75). Former players had significantly lower levels of NE (mean difference = -0.114, 95% CI -0.190 to -0.038), l-DOPA (-0.121, 95% CI -0.109 to -0.027), and DOPAC (-0.116, 95% CI -0.177 to -0.054) than UE participants. For NE and DOPAC, these overall group differences were primarily due to differences between the PRO and UE cohorts. No significant differences were found across TES-CTE probability subgroups or TES-parkinsonism diagnostic groups. Within the COL cohort, tested as post hoc analyses, higher CSF NE and l-DOPA were associated with higher neurobehavioral dysregulation factor scores, BAI total score, and worse executive functioning and processing speed. CSF DHPG and DOPAC were associated with impulsivity only in this subgroup. DISCUSSION: We observed reduced CSF catecholamine concentrations in former elite American football players, although the relationship with degree of RHI exposure and the clinical impact needs further study.

Medical Subject Headings

Humans; Male; Football (injuries); Cross-Sectional Studies; Middle Aged; Catecholamines (cerebrospinal fluid); Chronic Traumatic Encephalopathy (cerebrospinal fluid, diagnosis, etiology); Adult; 3,4-Dihydroxyphenylacetic Acid (cerebrospinal fluid); Biomarkers (cerebrospinal fluid); Athletes; Aged; Methoxyhydroxyphenylglycol (cerebrospinal fluid, analogs & derivatives); Dopamine (cerebrospinal fluid)

Publication Date

5-27-2025

Publication Title

Neurology

E-ISSN

1526-632X

Volume

104

Issue

10

First Page

e213584

PubMed ID

40258206

Digital Object Identifier (DOI)

10.1212/WNL.0000000000213584

Share

COinS